In addition, in a model of Alzheimer’s disease in mice, treatment with hesperidin (40 mg/kg, 90 days intragastric) increased HO1 and decreased levels of TNFα, CRP, NF-κB and MCP1, suppressing oxidative stress and inflammation [59]. The gene discussed is CCL2; the disease is early-onset autosomal dominant Alzheimer disease.